CELGENE CORP /DE/ Insider Trading $XLRN ACCELERON PHARMA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CELGENE CORP /DE/.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CELGENE CORP /DE/. CELGENE CORP /DE/ is 10% Owner in BRISTOL MYERS SQUIBB CO ($BMY) and in CELGENE CORP /DE/ ($CELG) and 10% Owner in CELGENE CORP /DE/ ($CELG) and 10% Owner in CASI Pharmaceuticals, Inc. ($CASI) and 10% Owner in Alliqua BioMedical, Inc. ($ALQA) and in ACCELERON PHARMA INC ($XLRN) and 10% Owner in ACCELERON PHARMA INC ($XLRN) and in SUTRO BIOPHARMA INC ($STRO) and 10% Owner in Abraxis BioScience, Inc. ($ABII) and 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and 10% Owner in CRISPR Therapeutics AG ($CRSP).

CELGENE CORP /DE/ in ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CELGENE CORP /DE/: 10% Owner
Holdings: 7,010,751 shares
Current Value: $166,435,229
Latest Transaction: Jul 13 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of CELGENE CORP /DE/ in ACCELERON PHARMA INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ABII, XLRN, ALQA, AGIO, BMY, CASI, CELG, CRSP, STRO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseX5.8838,979229,1970
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerSellS102.282,241229,2097,008,5107 M to 7 M (-0.03 %)
Jul 13 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyX5.8838,979229,1977,010,7517 M to 7 M (+0.56 %)
Jul 06 2020XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP92.50108,1089,999,9906,971,7726.9 M to 7 M (+1.58 %)
Jan 22 2019XLRNACCELERON PHARMA I ...CELGENE CORP /DE/BuyP43.00706,20630,366,8586,824,6856.1 M to 6.8 M (+11.54 %)
Sep 25 2017XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP37.00745,59227,586,9046,118,4795.4 M to 6.1 M (+13.88 %)
Jan 11 2016XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP40.00800,00032,000,0005,372,8874.6 M to 5.4 M (+17.49 %)
May 06 2014XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP42.861,100,00047,146,0004,572,8873.5 M to 4.6 M (+31.67 %)
Jan 29 2014XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP50.00300,00015,000,0003,472,8873.2 M to 3.5 M (+9.46 %)
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseC0.001,990,44600
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseJ0.0036,49600
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerOption ExerciseC0.00457,87500
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyP15.00666,66710,000,0053,172,8872.5 M to 3.2 M (+26.60 %)
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyC0.001,990,44602,506,220515.8 K to 2.5 M (+385.91 %)
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyJ0.0057,8990515,774457.9 K to 515.8 K (+12.65 %)
Sep 26 2013XLRNACCELERON PHARMA I ...CELGENE CORP /DE/10% OwnerBuyC0.00457,8750457,8750 to 457.9 K

Page:   1